Previous close | 48.98 |
Open | 48.24 |
Bid | 48.81 x 300 |
Ask | 48.89 x 100 |
Day's range | 48.11 - 48.86 |
52-week range | 42.63 - 55.72 |
Volume | |
Avg. volume | 2,027,834 |
Market cap | 123.373B |
Beta (5Y monthly) | 0.42 |
PE ratio (TTM) | 24.93 |
EPS (TTM) | 1.96 |
Earnings date | 25 Jul 2024 |
Forward dividend & yield | 2.04 (4.16%) |
Ex-dividend date | 09 May 2024 |
1y target est | 59.12 |
Moderna said Monday its Covid/flu vaccine topped rivals from GSK and Sanofi, and its own Spikevax shot. But Moderna stock fell.
GSK's Arexvy becomes the first RSV vaccine approved for adults aged 50-59 who are at high risk.
Denali Therapeutics (DNLI) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.